409A Valuation Outside the US: What Actually Applies If You're Not a Delaware C-Corp

If your startup isn't a Delaware C-corp and has no employees who are US taxpayers, you don't need a 409A valuation — 409A is a US Internal Revenue Code provision with no authority over your company. What you do need is a defensible, board-documented fair market value for setting option strike prices, and the mechanism for that depends on where you're incorporated: EMI rules in the UK, Rule 11UA in India, IFRS 2 for financial reporting almost everywhere, and a board resolution with stated methodology in most of the Gulf and Africa, where no statutory valuation regime exists at all.

Founders outside the US keep running into 409A anyway, because nearly everything written about ESOPs assumes a Delaware cap table. A Saudi or Nigerian founder copies a YC template, sees "409A valuation required before granting options," and either pays a US valuation firm for a compliance step they don't owe, or ignores the whole question and grants options at a strike price nobody can defend later. Both are wrong. Here's what actually applies.

What 409A is actually for

Section 409A of the US Internal Revenue Code governs non-qualified deferred compensation, and stock options fall under it because an option granted below fair market value is treated as deferred comp the IRS wants to tax immediately, with penalties, rather than at exercise. The valuation exists to prove the strike price wasn't set artificially low. It requires a formal appraisal, typically refreshed every 12 months or after a material event like a priced round, and it protects the company and the option holder from a specific US tax exposure.

None of that exposure exists for a company with no US taxpayers on the cap table. The IRS has no jurisdiction over a Kenyan company granting options to a Kenyan employee. The rule simply doesn't reach that transaction.

When 409A actually does apply to a non-US company

The trigger isn't where the company is incorporated — it's the tax status of the option holder. 409A reaches a non-US company the moment it grants options to:

• A US citizen, anywhere in the world
• A US green card holder, anywhere in the world
• A US tax resident (someone who meets the substantial-presence test, even on a work visa)

This is the scenario stock options for international employees gets wrong most often in the other direction — founders assume the company's incorporation decides the tax rules, when it's actually the individual employee's tax residency that pulls a specific grant into 409A's reach, regardless of what governs every other grant on the same cap table. A UAE startup with one Dubai-based US citizen on the team technically needs a defensible 409A-compliant valuation for that one person's grants, even though nobody else's grant is affected.

Companies actively planning a Delaware flip or a US listing should also get ahead of this — building a 409A-ready valuation history before it's legally required is cheaper than reconstructing one under deal pressure.

What applies instead, by jurisdiction

UK: EMI (Enterprise Management Incentive) valuations are agreed directly with HMRC before grant, and the tax treatment is genuinely favorable if the company and employees qualify. EMI valuations often land far below what a 409A valuation would produce for the same company at the same moment — EMI shares are routinely priced at a nominal fraction of a penny, because the scheme is built around tax-advantaged treatment rather than US-style fair-value strictness. An EMI valuation is not a substitute for 409A if you also have US employees; it only governs the UK grants.

India: Rule 11UA of the Income Tax Rules sets the fair market value standard, typically via a registered merchant banker or chartered accountant using discounted cash flow or net asset value methods. This is the number that determines the taxable perquisite an employee owes on exercise. A flipped entity with a US parent runs a 409A valuation on the US side and Rule 11UA (or its practical equivalent) on the Indian side — two separate numbers for two separate tax systems, not one translated into the other.

Saudi Arabia, UAE, and most of the Gulf: There's no statutory valuation regime equivalent to 409A or EMI. What governs is IFRS 2 for financial reporting — the option grant has to be fairly valued and expensed over the vesting period in the company's accounts — plus whatever fair market value the board documents when it approves the grant. In practice, the board resolution and its stated methodology (last round price, a comparable-company multiple, or a DCF for pre-revenue companies) is the standard. This is the same gap ESOP in the UAE covers from the instrument side: DIFC and ADGM free-zone entities have more established option-plan precedent than UAE mainland, but neither has a government-mandated valuation step.

Nigeria, Kenya, and most of Sub-Saharan Africa: Same pattern as the Gulf — IFRS or local GAAP equivalent governs the accounting entry, and the board sets and documents FMV for the grant itself. No independent appraisal is legally required at the pre-Series-B stage most Govy readers are at, though a board that's never updated its number since the seed round is setting itself up for an awkward diligence conversation at the next raise.

Southeast Asia (Singapore, Indonesia, Philippines): Mostly the same board-documented approach, though Singapore-incorporated holding structures sometimes layer in Monetary Authority of Singapore disclosure considerations if the company has outside investors with reporting requirements — worth a one-time check with local counsel rather than something that changes the valuation mechanics themselves.

Setting a number the board can actually defend

Outside the formal regimes (US 409A, UK EMI, India Rule 11UA), the real standard is: can you show your reasoning if someone asks in twelve months? That means the board resolution approving the grant should state which method was used and why:

• Recent priced round. If you closed a round in the last 6-12 months, that valuation is your strongest anchor — discount it for the lower liquidity and earlier stage of common stock versus the preferred stock investors bought, and document the discount rate you chose.
• Comparable companies. Revenue or user-base multiples from similarly staged companies in your sector and region, adjusted for the obvious differences.
• Discounted cash flow. The fallback for pre-revenue companies with nothing else to anchor to — weakest method, but defensible if it's the only one available and it's documented.

What doesn't hold up: a strike price set once at incorporation and never revisited through two priced rounds, or a number picked because it's "round" rather than because it traces to a method. The absence of a 409A-style annual refresh requirement outside the US isn't permission to never update the number — it's the absence of a deadline, not the absence of an obligation.

Where this breaks cap tables in practice

The actual failure mode isn't a wrong valuation — it's a cap table that can't show which valuation applied to which grant. A company with one US-taxpayer employee, several EMI-eligible UK hires, and a dozen Gulf-based employees is running three different fair-value regimes on one option pool, and a spreadsheet tracking a single "strike price" column per person loses the method and date each number came from. When an investor's counsel asks "how did you set this," the founder needs the board resolution and methodology behind each grant, not just the final figure.

Govy generates jurisdiction-aware ESOP grant agreements for Delaware, the UAE, Saudi Arabia, and the UK, and ties every grant to the board resolution that approved it on the same append-only ledger as the rest of the cap table. Govy is not a 409A or independent valuation provider — that appraisal, when you actually need one, still comes from a qualified valuation firm or merchant banker. What Govy does is keep the resulting number, the method, and the approval attached to the grant permanently, so the record survives the next round instead of living in someone's email from eighteen months ago. See how it works.

FAQ

Does my startup need a 409A valuation if we're incorporated outside the US? Not unless you're granting options to someone who is a US taxpayer — a US citizen, green card holder, or US tax resident, regardless of where they physically work. Section 409A is a provision of the US Internal Revenue Code; it has no legal force over a company with no US option holders. A UAE or Kenyan company issuing options only to local or regional employees has nothing to file under 409A, full stop.

What replaces 409A for setting a fair strike price outside the US? A board-approved fair market value, documented with whatever method the board actually used — a recent priced round, a comparable-company multiple, or a discounted cash flow for pre-revenue companies. The UK has EMI valuations agreed with HMRC, India has Rule 11UA valuations from a registered merchant banker or chartered accountant, and most of MENA and Africa has no statutory regime at all, which means the board resolution and its stated methodology is the standard you'll be judged against later, by auditors or acquirers.

Is a 409A valuation the same thing as an IFRS 2 share-based payment valuation? No, and conflating them is a common mistake. 409A sets a defensible strike price for US tax purposes. IFRS 2 — the accounting standard most non-US companies actually have to follow — values the options for expensing them on the income statement, using option-pricing models like Black-Scholes. A company can owe an IFRS 2 valuation for its financial statements while owing nothing under 409A, because they answer different questions for different audiences.

Do I need an independent valuation firm, or can the board just decide? Below a certain size, most non-US boards set FMV themselves and document the reasoning — recent funding evidence, comparable deals, or a simple DCF — in the resolution that approves the grant. There's no 12-month refresh rule outside the US like there is under 409A, but a stale number you haven't revisited since before your last priced round won't survive diligence. Companies planning a US listing, a Delaware flip, or US employee grants should get an independent valuation regardless, since that's the one scenario where 409A's rules do start to apply.

What happens if I just copy a US ESOP template that references 409A into a non-US company? You end up with a grant agreement that cites a US tax provision with no jurisdiction over your company or your employees, which confuses auditors, investors, and the employees themselves about what rule actually governs their strike price. It also usually means the document was never adapted to the exercise windows, tax treatment, or board-approval language your actual jurisdiction requires — the 409A reference is a symptom of a template that wasn't localized, not a feature worth keeping.